![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, March 07, 2024 11:42:08 AM
-- Did they ever really intend any African Trials?
-- Did they ever get any results from said volunteer trials?
-- Is Chandra even still legally with ENZC other than being a preferred shareholder?
-- Is the lab at A&M even still open at the PreClinical Trial center? We'll know on 4/24/2024.
-- Are there any proven results even in a 1-person test result for Clone3 or Clone7 ??
-- Are half of the listed Board Members doing anything with ENZC now?
Some of the above may sound silly, until you begin to think about it and review all DD.
If I see a patent approval spike by late Summer or earlier, I'm probably selling it all.
As always, I'd be happy to be wrong, but I've seen a lot of these. ENZC had more ground underneath them than most OTC Biopharma's, but it's all crumbling now.
GLTA
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM